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Abstract.Means to cause an immunogenic cell death could lead to signiﬁcant insight into how cancer escapes immune control. In this study,
we screened a library of ﬁve pyrrole–imidazole polyamides coding for diﬀerent DNA sequences in a model of B-cell lymphoma for the upre-
gulation of surface calreticulin, a pro-phagocytosis signal implicated in immunogenic cell death. We found that hairpin polyamide 1 triggers
the release of the damage-associated molecular patterns calreticulin, ATP and HMGB1 in a slow necrotic-type cell death. Consistent with this
signaling, we observed an increase in the rate of phagocytosis by macrophages after the cancer cells were exposed to polyamide 1. The DNA
sequence preference of polyamide 1 is 5′-WGGGTW-3′ (where W = A/T), indicated by the pairing rules and conﬁrmed by the Bind-n-Seq
method. The close correspondence of this sequence with the telomere-repeat sequence suggests a potential mechanism of action through
ligand binding at the telomere. This study reveals a chemical means to trigger an inﬂammatory necrotic cell death in cancer cells.
Key words: Py-Im Polyamide, damage-associated molecular patterns, necrotic cell death, immunogenic cell death, DNA-binding small
molecule, telomere sequence.
Introduction
Avoidance of immune destruction has been called the seventh
hallmark of cancer (Dunn et al. 2004a; Hanahan &Weinberg,
2011). According to the immuno-editing paradigm, the im-
mune system recognizes and destroys those proto-oncogenic
lesions capable of triggering an immune response, while those
that escape immune control grow to become clinically detect-
able disease (Dunn et al. 2004b; Koebel et al. 2007; Schreiber
et al. 2011; O’Sullivan et al. 2012). Studies suggest that thera-
pies that enlist the immune system maintain more durable
disease control in the clinical setting (Eggermont et al.
2014). Chemical methods to cause immunogenicity in cancer
cells would be an important tool toward understanding
immunomodulation in the treatment of cancer. A prerequi-
site for the activation of an anti-cancer immune response
is the recognition of the damaged cells as a threat. Damaged
cells release immunostimulatory molecules, called damage-
associated molecular patterns (DAMPs), to recruit and acti-
vate professional phagocytes such as macrophages and den-
dritic cells (Matzinger, 2002; Obeid et al. 2007; Jaiswal et al.
2010). These antigen-presenting cells engulf and process the
cancer cells to further prime the immune system for targeted
elimination of cancer (Tseng et al. 2013).
Although most chemotherapeutic regimens cause a non-
immunogenic or even tolerogenic cell death, recent reports
suggest anthracyclins or γ-radiation are particularly eﬀective
because they result in the release of DAMPs (Obeid et al.
2007; Zitvogel et al. 2008). The extracellular exposure of
the intracellularly abundant molecules calreticulin (CRT),
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HMGB1 and ATP have been suggested to form a spatiotem-
poral code for immunogenicity (Zitvogel et al. 2010; Kepp
et al. 2011). The presentation of CRT, an abundant
ER-resident chaperone protein, to the cell surface was ident-
iﬁed as a necessary and suﬃcient pro-phagocytic signal for
professional phagocytes (Obeid et al. 2007). The study
showed that stimulation of CRT surface expression by
anthracyclins or adsorbtion of the calreticulin protein on
the cell surface was suﬃcient to elicit an anti-cancer im-
mune response in syngeneic mice (Obeid et al. 2007).
Weissman and co-workers further demonstrated in the
Raji cell line, a model of human B-cell non-Hodgkin’s lym-
phoma, that CRT is the dominant pro-phagocytosis signal
which is necessary for engulfment by human macrophages
(Chao et al. 2010). Furthermore, ATP released from the cyto-
sol into the local microenvironment serves as a lymphocyte
recruiting and activating chemokine (Idzko et al. 2002;
Aymeric et al. 2010). Lastly, the nucleus-resident protein
HMGB1 can be secreted into the surroundings as an inﬂam-
matory adjuvant and was shown to be necessary for a durable
anti-cancer response in mice (Rovere-Querini et al. 2004;
Guerriero et al. 2011). Identiﬁcation of additional smallmole-
cules that trigger the release of these DAMPs from tumor cells
would be of utility to the ﬁeld in addressing the heterogeneity
of cancers. We became interested in expanding the examined
chemical space for compounds capable of causing an immu-
nogenic cell death. Because the DNA damage pathway has
been implicated in immunogenic signaling (Gasser et al.
2005) and anthracyclins are DNA-intercalating ligands, we
sought to explore a class ofminor grooveDNA-binding oligo-
mers hitherto not studied for this biological activity.
Hairpin pyrrole–imidazole (Py–Im) polyamides are a class
of sequence-speciﬁc oligomers that bind in the minor
groove of DNA (Wade et al. 1992; Trauger et al. 1996;
Kielkopf et al. 1998a, b; White et al. 1997, 1998).
Sequence preference is achieved by the pair-wise, co-facial
arrangement of aromatic amino acids that distinguish the
edges of the four Watson–Crick base pairs as shown in
Fig. 1a (Dervan & Edelson, 2003). Pairing rules for pro-
grammable speciﬁcity have been established: Im/Py speciﬁes
a G•C base pair, Hp/Py codes for T•A base pairs and Py/Py
binds both T•A/A•T (White et al. 1998). Eight-ring hairpin
polyamides are linked in an antiparallel fashion by a central
aliphatic γ-aminobutyric acid unit (Mrksich et al. 1994).
Polyamides of this hairpin architecture have aﬃnities for
match sites similar in magnitude to natural DNA-binding
proteins, with Ka’s of 10
8–1010 M−1 (Hsu et al. 2007).
Eight-ring hairpins of this class are cell-permeable and
modulate transcription in both cells and mice (Nickols
et al. 2007; Nickols & Dervan, 2007; Raskatov et al. 2012;
Yang et al. 2013). In this study, we screened a small library
of Py–Im polyamides coding for diﬀerent six base pair DNA
sequences in Raji cells for the upregulation of surface calre-
ticulin. We found one hairpin polyamide which displayed
activity in this screen and characterize its potential for caus-
ing an immunogenic cell death.
Materials and methods
Chemicals and reagents
All chemicalswerepurchased fromSigma-Aldrichunless other-
wise noted. Py–Impolyamides were synthesized bymicrowave-
assisted, solid-phase synthesis on Kaiser oxime resin
(Novabiochem) according to previously described protocols
(Baird & Dervan, 1996; Puckett et al. 2012). Polyamide 5 was
synthesized on hydrazine resin (855037, Novabiochem) in the
same manner as the other polyamides and cleaved from resin
in the same manner after 10 min oxidation of the hydrazine
by Cu(II)SO4 in pyridine and DMF. Polyamides were puriﬁed
by reverse-phase HPLC and lyophilized. EZ-Link NHS-
PEG4-biotin (Pierce) was conjugated in 5% Hünig’s base
in DMF. Purity and identity of compounds were veriﬁed
by analytical HPLC and matrix-assisted laser desorption/
ionization time-of-ﬂight mass spectrometry (SI Table 2).
Brefeldin Awas purchased from BD Biosciences, 7-AAD from
eBiosciences and Z-VAD-fmk from Promega. Antibodies pur-
chased from Abcam are: polyclonal rabbit anti-calreticulin
(ab2907), polyclonal rabbit anti-ERp57 (ab10287), polyclonal
goat anti-rabbit Alexa Fluor 488 (ab150081). Antibodies
from Life Technologies are: anti-Annexin V Alexa Fluor 488
conjugate (A13201) and mouse monoclonal anti-actin
(AM4302). Antibodies from Cell Signaling Technologies
are: rabbit polyclonal anti-PARP (9542) and rabbit mono-
clonal anti-phospho-H2AX (ser139, 9718).
Cell culture
Raji cells (ATCC) were maintained in RPMI media (Life
Technologies) with 10% fetal bovine serum (FBS, Omega
Scientiﬁc) and 5 mM glutamine (Life Technologies). K562
cells (ATCC) were cultured in IMDM (ATCC) media and
10% FBS. A549 and PC3 cells (ATCC) were maintained in
Kaign’s modiﬁed F-12 K media (Gibco) supplemented with
10% FBS and 5 mM glutamine. Peripheral blood macrophages
(Stemcell Technologies) were thawed and plated in DMEM
(ATCC) and supplemented with 5 mM glutamine and 10%
FBS for at least two days and no longer than 6 days before use.
Flow cytometry
Raji and K562 cells were plated at 1 × 105 cells ml−1 in
96-well plates at 100 μl and treated immediately after plat-
ing. A549 and PC3 cells were plated in 24-well plates at
6 × 104 cells ml−1 at 400 μl and were allowed to adhere over-
night prior to treatment. Adherent cells were harvested with
Accutase (Life Technologies).
For the CRT and ERp57 detection experiments, harvested
cells were washed with cold staining buﬀer: HBSS (Life
Technologies) with 2·5 mg ml−1 BSA (Amresco), 10 mM
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HEPES (Life Technologies), 0·1 mM MgCl2 (Life Technologies)
and DNAse (Roche). Cells were incubated with human FcR
block (eBiosciences) and primary antibody in cold staining
buﬀer. This was followed by washing and incubation with dye-
conjugated anti-rabbit secondary antibody. 7-AAD, forward-
and side-scatter were used to gate for live cells. Secondary
antibody alone was used as a control (SI Fig. 2). The median
ﬂuorescence intensity of live cells is normalized to non-
treatment. Data were acquired on the FACS Calibur and
analyzed with Flowjo software. Measurements and standard
deviations are in triplicate and representative of at least two in-
dependent experiments; asterisk indicates p < 0·05 by two-
tailed Student’s t test compared with non-treatment.
For cell death analysis ﬂow cytometry experiments, Raji cells
were harvested after treatment and washed with cold stain-
ing buﬀer and incubated with FcR block and dye-conjugated
anti-Annexin V. Cells were washed with staining buﬀer and
taken for immediate analysis. 7-AAD was added to samples
maintained at 4 °C and data was acquired soon thereafter on
the MACS VYB. Data was acquired in triplicate from two
independent experiments and analyzed with Flowjo (SI
Tables 5 and 6).
Bind-n-Seq of polyamide 1b
Highest aﬃnity DNA binding sites of polyamide–biotin
conjugate 1b were determined according to previously
reported methods (Meier et al. 2012). In brief, polyamide
1b was equilibrated at 25 or 250 nM overnight in a DNA li-
brary of all possible 21 mers. DNA bound to 1b was aﬃnity
puriﬁed with streptavidin magnetic beads (M-280
Dynabeads, Life Technologies) and eluted. Isolated DNA
was ampliﬁed by touchdown PCR and submitted for
sequencing on an Illumina HiSeq 2000 Genome Analyzer.
The MERMADE script was used to distribute data by bar-
code and a fasta ﬁle of a random 25% of sequences was gen-
erated for DREME motif analysis. Data are representative of
three independent experiments (SI Fig. 4).
DNA thermal denaturation assay
DNA of the sequence 5′-CTTAGGGTTAGC-3′ and its
complement were purchased from Integrated DNA
Technologies and annealed. The oligonucleotides were
mixed with hairpin polyamide 1 to a ﬁnal concentration
of 2 and 3 μM, respectively, in 1 mL total volume. An aque-
ous solution of 10 mM sodium cacodylate, 10 mM KCl, 10
mM MgCl2 and 5 mM CaCl2 at pH 7·0 was used as analysis
buﬀer. The assay utilized a Varian Cary 100 spectrophot-
ometer to heat samples to 90 °C, cool to a starting tempera-
ture of 25 °C, and then heat at a rate of 0·5 °C min−1 to 90 °
C. Denaturation proﬁles were recorded at λ = 260 nm and
melting temperatures were detected by the maximum of
the ﬁrst derivative. Data show the combined mean and
Fig. 1. Screen of Py–Im polyamide library 1–6 for stimulation of surface calreticulin (CRT) in Raji cells. (a) Py–Im polyamide recog-
nition of DNA minor groove and corresponding ball-and-stick notation. (b) Structures of compounds in polyamide library. (c) Surface ex-
pression of calreticulin measured by ﬂow cytometry, median ﬂuorescence normalized to non-treated control (NT). Cytotoxic controls
doxorubicin (Dox, 5 μM), mitoxantrone (Mtx, 1 μM) and etoposide (Eto, 30 μM). (d) Dose dependence of cell surface CRT to polyamide 1
was measured by ﬂow cytometry after 24 h treatment. Measurement and error bars of the standard deviation are in triplicate and rep-
resentative of two independent experiments; asterisk indicates p < 0·05 by two-tailed Student’s t test compared with NT.
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standard deviation of triplicate measurements from two in-
dependent experiments.
Immunoblot assays
Raji cells were plated at 105 cells ml−1 in 10 cm diameter
dishes and dosed with the indicated treatment. Cells were
washed with cold PBS and lysed for 10 min in lysis buﬀer
(50 mM Tris–HCl pH 7·4, 1 mM EDTA, 150 mM NaCl, 1%
Triton X-100) containing protease inhibitors (Complete,
Roche), 1 mM PMSF and phosphatase inhibitors. Samples
were clariﬁed by centrifugation at 14 000 × g for 10 min,
quantiﬁed with Bradford reagent (Bio-rad), denatured by
boiling in Laemmli buﬀer (LI-COR) for 5 min and separated
by sodium dodecyl sulfate–polyacrylamide gel electrophor-
esis using AnyKD gradient gels (Biorad). Protein was trans-
ferred to a PVDF membrane (Millipore) and blocked with
Odyssey blocking buﬀer (LI-COR). Both primary antibodies
and appropriate IR-dye conjugated secondary antibodies
(LI-COR) were incubated in blocking buﬀer with 0·2%
Tween. Anti-actin was used to control for equal loading
and experiments were done in at least two independent bio-
logical replicates. Bands were visualized on a LI-COR
Odyssey infrared imager.
ATP bioluminescence assay
Raji cells were plated into 96-well cell culture plates at 200 μl
per well and 105 cells ml−1, in quadruplicate per condition.
After the indicated treatment, media and cells were trans-
ferred to a 96-well PCR plate and centrifuged at 130 × g
for 5 min. The supernatant was collected for analysis of
ATP content using an ATP bioluminescence kit (FLAA,
Sigma). The assay was performed according to the manufac-
turer’s protocol and luminescence was measured using a
Flexstation 3. Measurements and standard deviation are
technical quadruplicate and biological triplicate. Asterisk
indicates p < 0·05 by two-tailed Student’s t test compared
with non-treatment.
HMGB1 ELISA
Raji cells were plated into 96-well cell culture plates at 100 μl
per well, 105 cells ml−1, in duplicate. Cells were treated with
polyamide 1 and 2 as indicated and the supernatant col-
lected. HMGB1 was measured using the Shino-Test ELISA
kit (IBL international) according to the manufacturer’s
instructions on the Flexstation 3. Measurement and stan-
dard deviations were determined from technical duplicate
from two independent replicates. Asterisk indicates p <
0·05 by two-tailed Student’s t test compared with
non-treatment.
Caspase luciferase assay
Raji cells were plated into 96-well cell culture plates at 100 μl
per well and 105 cells ml−1, in triplicate per condition.
Media was included as a blank control. After the indicated
treatment, media and cells were transferred to an opaque
white 96-well plate containing 100 μl in each well of the
caspase-dependent luciferase reagent, prepared as per the
manufacturer’s instructions (Caspase-Glo 3/7, Promega).
The mixture was left at room temperature for 1 h prior to
measurement on the Flexstation 3 (Molecular Devices).
Measurements and standard deviations were determined
in triplicate and done in biological duplicate.
Metabolic activity assay
Raji cells were plated into 96-well clear bottom cell culture
plates at 100 μl per well and 105 cells ml−1, in quadruplicate
per indicated condition. Media was used as a background
control. Metabolic activity was assessed using the WST-1 re-
agent (Roche) as per the manufacturer’s instructions.
Measurements and standard deviations were determined
in quadruplicate and done in biological duplicate.
Phagocytosis assay
Peripheral blood macrophages were plated at 2 × 104 cells
per well in 24- or 48-well plates in DMEM. Immediately
prior to use, macrophages were washed with HBSS and
stained with carboxyﬂuorescein diacetate succinimidyl
ester (CFSE, eBioscience) in HBSS for 5 min. Macrophages
were washed of excess dye and returned to DMEM for in-
cubation. Target Raji cells were plated in 96-well plates at
1 × 105 cells ml−1 in 200 μl of RPMI and treated as de-
scribed. Target A549 cells were plated in 24-well plates at
2 × 104 cells per well 15 h before beginning treatment.
After treatment, cells were harvested with Accutase if
necessary and washed with HBSS and incubated with
pHrodo succinimidyl ester (Life Technologies) diluted to
2 μM in HBSS for 5 min. Cells were then washed by centri-
fugation at 150 × g, re-suspended in DMEM, counted on a
Biorad TC10 cell counter, and 5 × 104 cells per well were
added to macrophages. After incubation for 2·5 h at 37 °C,
media and non-adherent cells in each sample were aspirated
and saved. Adherent cells were trypsinized, aspirated and
combined with saved media mixture. Cells were washed
once with PBS and ﬁxed in 1% formaldehyde and kept at
4 °C until assessment on the MACS VYB ﬂow cytometer.
The percentage of phagocytosis was calculated as the per-
centage of double positive cells among ﬂuorescein+ macro-
phages. Measurements and standard deviations are taken
from three independent experiments and asterisks indicate
p < 0·05 by two-tailed Student’s t test compared with
non-treatment.
Confocal microscopy
For images of phagocytosis, cells treated in the manner
described above were put on 35 mM glass-bottom dishes
(MatTek). Confocal images were acquired using a 40×
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oil immersion objective on a Zeiss LSM 5 Exciter
microscope.
Results
Polyamide 1 upregulates calreticulin on the cell
surface
We tested ﬁve Py–Im polyamides (1–5, full structures in SI
Fig. 1) that bind ﬁve unique DNA sequences (5′-WG
GGWW-3′, 5′-WGWWCW-3′, 5′-WGGWCW-3′, 5′-WT
WCGW-3′ and 5′-WCGCGW-3′, respectively, where W =
A/T) and have demonstrated biological activity (Fig. 1b)
(Swalley et al. 1996; Nickols & Dervan, 2007; Nickols
et al. 2007, 2013; Kang et al. 2014). Raji cells, which have
previously been utilized in CRT, phagocytosis, and immu-
notherapy animal models, were dosed at 5 μM for 24 h
with each of the polyamides 1–5. In addition, 5 μM doxoru-
bicin (Dox) and mitoxantrone (Mtx, 1 μM) were included as
representative anthracyclins. The topoisomerase inhibitor
etoposide (Eto, 30 μM) was also included for comparison.
A 4 h exposure time point was used to measure CRT due
to the high toxicity of these chemotherapeutics and to be
in the range of literature precedent (Obeid et al. 2007).
We measured surface CRT by ﬂow cytometry in a popu-
lation gated for live cells and saw a statistically signiﬁcant,
twofold increase in cells treated with only polyamide
1 (Fig. 1c). In contrast, we saw no activity with the other
polyamides 2–5 despite their structural similarity. Notably,
polyamide 2 has been most extensively studied among this
class and has shown activity in prostate cancer xenograft
models and DNA damage response (Yang et al. 2013;
Martínez et al. 2015). Remarkably, polyamides 3 and 1
share the same molar weight and composition of Im/Py
pairs, and only diﬀer by the exchange of one Im/Py ring
pair. To assess the structure activity relationship of the imi-
dazole trimer portion of the hairpin oligomer 1, we synthe-
sized and examined ImImIm polyamide 6. This was tested
because imidazoles are known to complex with calcium
and CRT is involved in calcium homeostasis (Michalak
et al. 2009). We did not, however, observe an increase of
CRT with polyamide 6, which suggests the imidazole trimer
alone is not suﬃcient to trigger the surface expression of
CRT. We observed no increase in CRT with the two anthra-
cyclins tested, Dox and Mtx, or with Eto. The diminished
response to anthracyclin treatment in Raji cells, as com-
pared with that reported in the literature with murine
colon cancer cells, reﬂects a known range of CRT response
to anthracyclins and may be attributable to a diﬀerence in
cell lines (Tuﬁ et al. 2008; Peters & Raghavan, 2011). We
next increased the treatment concentration of 1–25 and
50 μM and found that CRT exposure increased in a dose-
dependent manner (Fig. 1d, SI Fig. 2a). The results indicate
polyamide 1 is unique in our small library of compounds in
its modulation of surface expression of CRT.
Polyamide 1 preferentially binds the sequence
5′-WGGGTW-3′
Py–Im polyamides are a class of sequence-speciﬁc
DNA-binding ligands and the DNA-binding preferences
of polyamide 1 may be related to a mechanism of action.
By the pairing rules, polyamide 1 is a perfect match to
5′-WGGGWW-3′, not unlike the TTAGGG-repeat sequence
found in human telomeres. Indeed, dye-conjugated tandem
hairpin Py–Im polyamides that recognize 10 base pairs of
this repeat sequence can be used to stain telomeres in per-
meabilized cells (Maeshima et al. 2001; Kawamoto et al.
2013). We sought to conﬁrm the preferred binding sequence
motif of 1 using the Bind-n-Seq method. Bind-n-Seq cou-
ples aﬃnity enrichment with next-generation sequencing
to query genome-sized sequence space for high-aﬃnity
binding sequences (Meier et al. 2012). We modiﬁed polyam-
ide 1 at the C-terminal position with a biotin-label to aﬀord
1b (full structure in SI Fig. 1b) for submission to
Bind-n-Seq. Polyamide 1b strongly preferred binding the
DNA sequence motif of 5′-WGGGTW-3′ (Fig. 2a, SI
Table 4). We additionally conﬁrmed the aﬃnity of polyam-
ide 1 for this sequence by measuring the thermal stabiliza-
tion aﬀorded to sequence-matched double-stranded DNA
(Pilch et al. 1996). We tested a DNA fragment that included
the telomeric DNA sequence 5′-TTAGGGTTAG-3′
(Fig. 2b). Polyamide 1 stabilized the 12 base pair DNA frag-
ment by 11·5 °C, suggesting a high-aﬃnity hairpin polyam-
ide. Lastly, we detected a marker of DNA stress,
phosphorylation of serine 139 on the histone H2AX, after
treatment with polyamide 1 but not 2 (Fig. 2c). We chose
the 25 μM dose for this experiment and others described
below because it resulted in a robust sixfold increase in sur-
face CRT. We posit that the CRT eﬀect may be due to the
unique properties of the DNA target sequence of polyamide
1 in cell biology. The DNA stress, thermal denaturation and
Bind-n-Seq results together suggest the telomere sequence is
a plausible target for the mechanism of action of polyamide
1-mediated CRT exposure.
Polyamide 1 triggers CRT in a different manner than
do anthracyclins
To better understand the eﬀects of polyamide 1, we com-
pared its trigger of CRT with reports of CRT induction by
anthracyclins (Panaretakis et al. 2009). Anthracyclin-
induced CRT exposure has been described to occur with
the co-chaperone ERp57 by anterograde ER-Golgi transport
(Panaretakis et al. 2009). To interrogate whether polyamide
1 induces CRT export to the cell surface by ER–Golgi trans-
port, in Fig. 3a, we applied the Golgi transport inhibitor
Brefeldin A (B) to Raji cells (Lippincott-Schwartz et al.
1989). Due to the toxicity of B, we could only dose B for
12 h. With 24 h treatment with polyamide 1 and 12 h treat-
ment with B, we saw statistically signiﬁcant reduction of
CRT on the cell surface when compared with polyamide
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1 treatment alone (Fig. 3a). When polyamide 1 and B were
dosed together for 12 h, we saw near ablation of all polyam-
ide 1-induced CRT, demonstrating the necessity of this
pathway for transport. This further suggests CRT has a half-
life on the cell surface of at least 12 h. We additionally
measured co-chaperone ERp57 by ﬂow cytometry and
found that after treatment with 1 for 24 h, ERp57 increased
on the cell surface to a similar extent as did CRT,
approximately sixfold (Fig. 3b). These results are consistent
with previous reports that the translocation of these
ER-resident chaperones to the plasma membrane occurs
by anterograde ER–Golgi transport (Panaretakis et al. 2009).
Anthracyclin-induced CRT has previously been reported to
be mediated by a caspase 8- and caspase 3/7-dependent
pathway that can be disrupted with the pan-caspase inhibi-
tor Z-VAD-fmk (Z) (Panaretakis et al. 2009). Upon
co-dosing polyamide 1 with Z, however, we saw no decrease
in CRT exposure (Fig. 3c). This caspase-independence was
unexpected in light of literature precedent as well as the
Fig. 2. Preferred DNA-binding sequence of polyamide 1. (a) Polyamide 1b (SI Fig. 1b), the biotinylated analog of 1, was tested in a
Bind-n-Seq assay and found to preferentially bind the described DNA sequence motif. (b) Aﬃnity of 1 was assessed by a DNA thermal
stabilization assay against dsDNA containing the telomeric-repeat sequence 5′-TTAGGG-3′. (c) Immunoblot of γ-H2AX and actin control
after the indicated treatment.
Fig. 3. Treatment of Raji cells with polyamide 1 triggers anterograde CRT transport by a diﬀerent mechanism than previously reported
for anthracyclins. (a) Surface CRT was measured by ﬂow cytometry after Raji cells were treated with 25 μM polyamide 1 for 12 or 24 h
and Brefeldin A (B) for the ﬁnal 12 h. (b) Co-chaperone ERp57 was measured on the cell surface by ﬂow cytometry after 24 h treatment
with 1 at 25 μM. (c) Caspase inhibitor Z-VAD-fmk (Z, 10 μM) and polyamide 1 (25 μM) were dosed together for 24 h and assessed by
ﬂow cytometry for surface CRT. (d) Immunoblots for PARP cleavage and actin control after the indicated treatments are shown. All ﬂow
cytometry analyses were done in triplicate and are representative of at least two independent experiments. Error bars show standard
deviations and asterisks mark statistically signiﬁcant changes (p < 0·05) by two-tailed Student’s t test compared with non-treatment (un-
less another comparator is marked).
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cytotoxicity we observed of 1 during ﬂow cytometry ex-
periments. We conﬁrmed the lack of PARP cleavage, a cas-
pase substrate cleaved during apoptosis, by immunoblot
(Fig. 3d). We then directly measured caspase activity with
a luciferase assay after treatment with hairpin polyamides
1 and 2 as well as Eto and Dox (Fig. 4a). We measured a
slight increase, approximately 1·2-fold, upon treatment
with 1 for 24 h and no increase after treatment with 2. In
contrast, we measured signiﬁcant increases of approximately
15-fold each after treatment with Eto and Dox (Fig. 4a).
The lack of caspase-dependence and caspase activation
would suggest the trigger of CRT by 1 is diﬀerent from
anthracyclin DNA intercalators.
Polyamide 1 induces a slow necrotic-type cell death
We measured cytotoxicity via the metabolic rate with the
WST-1 reagent in a colorimetric assay. We were surprised
to ﬁnd that treatment with 1, at both 24 and 48 h, had little
eﬀect on the bioreduction of WST-1 to the formazan dye,
suggesting no diminution of metabolic rate (Fig. 4b). This
is in stark contrast to the cytotoxic Eto and Dox which
showed drastic reduction in cellular metabolism, consistent
with the apoptotic program. This led us to assess whether
polyamide 1 may direct the Raji cells toward programmed
necrosis. Necrosis is an immunogenic, inﬂammatory type
of cell death that is usually attributed to harsh physical in-
sult such as freeze–thaw cycles. Recently, a biologically con-
trolled necrosis program has been described where cells
undergo early plasma membrane permeabilization with ac-
tive inﬂammatory signaling and an oxidative burst
(Kaczmarek et al. 2013). We compared the mode of cell
death after 24 h treatment with hairpins 1 and 2, or Eto
by ﬂow cytometry. We analyzed plasma membrane per-
meability and phosphatidylserine exposure on the cell sur-
face to determine subpopulations of live, necrotic and
apoptotic cells after compound exposure. Plasma membrane
permeability was assessed through 7-AAD dye exclusion
and phosphatidylserine was visualized by dye-conjugated
annexin V binding. We found that the non-treated control
and treatment with hairpin 2 at 24 h resulted in little cell
death, but treatment with 1 or Eto caused signiﬁcant cell
death (Fig. 4c). Remarkably, there was a distinct and sub-
stantial population of cells treated with 1 that lost plasma
membrane integrity without phosphatidylserine exposure,
indicative of a necrotic cell death. We observed a continuous
population from the upper left to the upper right quadrant
in cells treated with polyamide 1, suggestive of progressive
phosphatidylserine exposure in permeabilized cells. The
upper right quadrant in all treatment conditions is secondary
necrosis as there are no phagocytes to remove apoptotic or
necrotic bodies. There are nearly no cells in the etoposide-
treated condition that lie in the upper left quadrant, reﬂective
of a canonical apoptotic cell deathwith intactmembranes dis-
playing phosphatidylserine. The anthracyclins could not be
used in this assay due to their inherent ﬂuorescence. We
further did a time course of the necrotic eﬀect of polyamide
1 at 12, 24 and 48 h and found that the cells began permeabi-
lization as early as 12 h, and underwent further necrosis by 48
h (Fig. 4d). These assays together suggest polyamide 1 prefer-
entially tracks Raji cells toward a slow, necrotic-type cell death
even though the cells are capable of apoptosis.
Polyamide 1 triggers the release of DAMPs
The inﬂammatory nature of necrotic cell death can be
attributed in part to the release of immune-activating
DAMPs (Rubartelli & Lotze, 2007; Kaczmarek et al. 2013).
We measured levels of CRT, ATP and HMGB1 after poly-
amide 1 treatment as these DAMPs have been described
as key factors in a spatiotemporal code of immunogenicity
(Zitvogel et al. 2010; Kepp et al. 2011). We included poly-
amide 2 as an in-class control because 2 has been exten-
sively studied in other cancer models (Yang et al. 2013).
We measured CRT by ﬂow cytometry after 24 and 48 h of
compound exposure at 25 μM and observed a decreasing
trend for surface CRT (Fig. 5a), consistent with reports
that CRT is an early response signal (Kepp et al. 2011).
Even at the 25 μM concentration of polyamide 2, we detected
no increase of CRT after 24 h treatment. Extracellullar ATP
was measured with a bioluminescence assay of the super-
natant after the same treatment regime (Fig. 5b). The ATP
detected in the media after treatment with hairpin 1 was
greatly increased over the non-treated condition. We next
analyzed the release of HMGB1 by running a sandwich
ELISA for HMGB1 in the supernatant. After treatment for
24 or 48 h with 1, a signiﬁcant increase in excreted
HMGB1 was detected in the media (Fig. 5c). The polyamide
1-mediated release of CRT, ATP and HMGB1 in this tem-
poral pattern is consistent with immunogenic signaling de-
scribed in the literature.
Polyamide 1 treated Raji cells are subject to
phagocytosis
Necrotic cell death with an abundance of externalized CRT
and other released immunogenic DAMPs should increase
phagocytosis. We obtained human peripheral blood macro-
phages and incubated them for 2·5 h with Raji cells treated
with 1 or 2 at 25 μM for 24 or 48 h. The Raji cells’ plasma
membrane was covalently decorated with a pH-sensitive
dye (pHrodo) that is activated when engulfed. Macrophages
were marked with a cell-permeable ﬂuorescein dye (Fig. 6a).
Macrophages that phagocytosed Raji cells are double posi-
tive for ﬂuorescein and activated pHrodo dye. In each exper-
iment, 1000 macrophages were analyzed by ﬂow cytometry
per condition. Compared with non-treatment, we found that
a greater percentage of macrophages incubated with poly-
amide 1-treated Raji cells were double positive, and more
so at 48 than 24 h (Fig. 6b, SI Fig. 7). We saw little change
when macrophages were incubated with cells treated with 2.
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This indicates macrophages phagocytosed Raji cells more ef-
ﬁciently after treatment with polyamide 1. We also tested
the lower concentration of 5 μM of 1 used in the library
screening assay, anticipating that immunogenicity may be
a threshold eﬀect and that 5 μM may be a more reasonable
in vivo concentration. We found that the treatment of Raji
cells with this lower concentration still increased the per-
centage of phagocytosis by macrophages (Fig. 6c). We
Fig. 4. Raji cells undergo a slow, necrotic type cell death after treatment with polyamide 1. (a) Caspase 3/7 activity was assessed by a lu-
ciferase assay after the indicated treatment. Measurement is representative of two independent experiments and error bars show standard
deviations of triplicate measurement. (b) Cellular metabolism as a proxy for cytotoxicity was measured with a WST-1 assay. Cytotoxic
controls etoposide (Eto, 30 μM) and doxorubicin (Dox, 5 μM) were included. Measurements were normalized to non-treatment. Graph is
representative of two independent experiments and error bars represent standard deviations of technical quadruplicate. (c) Flow cytometry
assessment of Raji cells treated with the indicated compounds for 24 h and stained for plasma membrane permeability (7-AAD) and
phosphatidylserine exposure (Annexin V). Live: lower left; early necrotic: upper left; secondary necrotic: upper right; apoptotic: lower
right. Representative plots shown of triplicate measurements from two independent experiments. (d) Assessment as in (b) after 12, 24
and 48 h exposure to polyamide 1 at 25 μM.
Fig. 5. Immunogenic signaling is triggered by polyamide 1 treatment. (a) CRT was measured by ﬂow cytometry after 24 and 48 h treat-
ment with 1 or 2 at 25 μM. (b) Extracellular ATP was measured by a bioluminescence assay after the same treatment. (c) HMGB1 in the
supernatant was measured by ELISA after treatment as in (a) and (b). CRT ﬂow cytometry and HMGB1 ELISA were measured in tripli-
cate from at least two independent experiments. ATP was measured in quadruplicate in three independent experiments. Error bars show
standard deviations and asterisks indicate statistically signiﬁcant increases (two-tailed Student’s t test, p < 0·05) compared with
non-treatment.
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then veriﬁed the phagocytosis assay results with confocal
microscopy to ensure that Raji cells were indeed phagocy-
tosed rather than externally adherent (Fig. 6d). The images
show that a fraction of macrophages have internalized Raji
cells, which ﬂuoresce with the activated pHrodo dye. The
brightﬁeld composite image shows free Raji cells in grey
which are not engulfed by macrophages and lack a robust
pHrodo signal. The bottom row shows a magniﬁcation of
a macrophage after phagocytosis of a large Raji cell body.
Polyamide 1 triggers CRT and phagocytosis in other
cancer cell lines
We next explored whether this eﬀect might be speciﬁc to the
Raji B-cell lymphoma model or more general in other can-
cer cell lines. We screened the A549 lung adenocarcinoma
cell line, K562 B-cell leukemia cell line and the PC3 prostate
cancer cell line for CRT translocation after treatment with 1.
We observed approximately fourfold increase in CRT sur-
face expression in the A549 and PC3 cell lines (Fig. 6e).
Surprisingly, we did not observe an increase in the K562
B-cell leukemia cell line (Fig. 6e) though they are closest
in lineage with the Raji B cells. We then tested the A549
cell line in the phagocytosis assay after 24 h treatment
with 25 μM polyamide 1. Even though the adherent A549
cell line presents a more diﬃcult target for macrophages,
as compared with non-adherent Raji cells, we measured
an observable increase in A549 phagocytosis after treatment
with polyamide 1 (Fig. 6f). These results show the eﬀects of
polyamide 1 extend beyond the Raji cell line to cells of dif-
ferent lineages but are not completely general.
Discussion
In this study, we have discovered a Py–Im polyamide cap-
able of triggering the release of immunogenic signals in a
necrotic-type cell death. Treatment with polyamide 1
increased the externalization of CRT, HMGB1 and ATP,
which have been characterized to be key signals of immuno-
genicity. We further observed that polyamide 1 causes per-
meabilization of the plasma membrane in a subpopulation
of treated Raji cells, which grows from 12 to 48 h. This
occurs even as the apoptotic cell death pathway remains
competent, as demonstrated by the distribution proﬁle
observed after Eto treatment of Raji cells. We conclude
that polyamide 1 preferentially triggers a necrotic-type,
likely highly immunogenic cell death, an eﬀect we are not
aware has precedent with a small molecule synthetic ligand.
Phagocytosis by antigen-presenting cells is a critical step in a
chain of events toward leveraging the speciﬁcity and power
of the immune system toward attacking the oﬀending target.
We saw increased phagocytosis of polyamide 1- treated cells
Fig. 6. Treatment of cells with 1 increases phagocytosis by human macrophages. (a) Schematic diagram of ﬂuorescence-revealed phago-
cytosis using the pH-sensitive pHrodo dye. (b) Raji cells treated with the indicated compound at 25 μM for 24 or 48 h were incubated
with human macrophages for 2·5 h. Fluorescein+ cells were assessed by ﬂow cytometry for double-positive cells to determine % phago-
cytosis. (c) Raji cells were treated with a lower dose of 5 μM of 1 for 24 and 48 h and assessed for phagocytosis by macrophages in the
same manner as in (b). (d) Fluorescent images of cells prepared as in (B) are shown. Human macrophages are marked green, free Raji
cells are gray in the brightﬁeld composite image, and magenta-colored bodies inside macrophages are phagocytosed Raji cells with acti-
vated pHrodo. Yellow box in top row is magniﬁed in bottom row images. (e) The cell lines A549, K562 and PC3 were treated with poly-
amide 1 for 24 h and screened by ﬂow cytometry for surface CRT. Measurements and standard deviations are in technical triplicate and
biological duplicate. (f) A549 lung carcinoma cells treated with 1 for 24 h was subjected to human macrophages as described above.
Graphs show mean and standard deviation from three independent experiments for (b), (c), (e) and (f). Asterisks indicate statistically sig-
niﬁcant increases (Student’s two-tailed t test, p < 0·05) compared with the non-treated condition. Images in (d) are representative of two
independent experiments.
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by macrophages, as would be expected upon the death of
Raji cells with externalized pro-phagocytic CRT. The
observed phagocytosis and inﬂammatory DAMPs released
into the tumor microenvironment makes plausible that
the immune system would become primed toward antigens
of Raji cells. Reports have shown engulfment by macro-
phages can activate an eﬀective anti-cancer T cell response
(Tseng et al. 2013). The application of polyamide 1 on can-
cer in the context of a full immune system remains to be
explored.
That the DNA sequence preference of 1 is identical with
that of human telomeres was indicated by the pairing
rules and conﬁrmed by Bind-n-Seq. Whether the mechan-
ism of action for polyamide 1 is through its sequence-
speciﬁc DNA binding capacity remains an open question.
Though polyamides have generally been characterized to
act in a DNA-binding mode, we cannot exclude that poly-
amide 1 may act as an aptamer binding to unknown target
proteins. The translocation of CRT after polyamide 1 treat-
ment was observed in multiple, though not all, cell lines and
suggests there is a conserved pathway that leads to this
phenotype that is retained in many cancer cell lines. We ex-
pect the elucidation of the mechanism of action will reveal
important signaling networks involved in immunosurveil-
lance of cancer cells.
Conclusion
The eﬀects of polyamide 1 are compelling because immuno-
genic cancer cell death is cleared in the natural setting and
thus diﬃcult to observe. Further study may reveal tumor
suppressive signaling pathways that can be exploited to ex-
trinsically control cancer even as cell-intrinsic mechanisms
fail. The failure of anthracyclins to elicit CRT in Raji cells
when it has previously been shown to be eﬀective in CT26
murine colon cancer cells (Obeid et al. 2007) underscores
the heterogeneity of cancers. As cancers have heterogeneous
mechanisms for evading elimination by the immune system,
a corresponding diversity of immunogenicity agents will be
important for both shedding light on new biology and de-
veloping immuno-oncologic therapies.
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